FH is mainly related to the occurrence of loss-of-function alterations in the LDLR (60–80% of patients) and APOB (5–10%) genes or gain-of-function variants in the PCSK9 gene (<1%). This evidence concerns the gene LDLR and familial hyperaldosteronism.